Cholangitis

April 19 marks World Liver Day, a global effort to raise awareness about liver health and the growing burden of liver disease. This year’s…

Long-term, off-label treatment with fenofibrate significantly reduces liver damage markers and improves prognostic scores in primary biliary cholangitis (PBC) patients who do not respond…

April is officially recognized in the U.S. as National Donate Life Month, an opportunity to highlight the extraordinary impact of organ donation, and the…

An artificial intelligence (AI) tool that analyzes patterns in blood molecules may help distinguish people with primary sclerosing cholangitis (PSC) and inflammatory bowel disease…

Primary biliary cholangitis (PBC) patients who have irreversible liver scarring that affects the organ’s function are more likely to experience liver function recovery if…

Lynavoy (linerixibat) is now approved in the U.S. as an oral treatment for cholestatic pruritus, or intense itch due to problems in how the digestive…

A noninvasive MRI-based approach may help assess disease severity and predict the likelihood of serious complications in people with primary sclerosing cholangitis (PSC), a…

Hispanic people with primary biliary cholangitis (PBC) are significantly less likely to achieve complete lab-based remission — defined as a normalization of the liver damage…

Use of the experimental immune-modulating therapy CNP-104 in adults with primary biliary cholangitis (PBC) participating in a U.S. clinical trial led to greater reductions in markers…

People with primary biliary cholangitis (PBC) who don’t start treatment after being diagnosed with the liver disease end up hospitalized more often and for…